Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Herbert Yih-Fuu Lin, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Herbert Lin and Dennis Brown.
Connection Strength

0.454
  1. Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells. J Am Soc Nephrol. 2010 Apr; 21(4):666-77.
    View in: PubMed
    Score: 0.112
  2. The soluble transforming growth factor-beta receptor: advantages and applications. Int J Biochem Cell Biol. 2009 Mar; 41(3):472-6.
    View in: PubMed
    Score: 0.097
  3. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes. 2007 Feb; 56(2):380-8.
    View in: PubMed
    Score: 0.091
  4. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment. Biol Cell. 2006 Apr; 98(4):215-32.
    View in: PubMed
    Score: 0.086
  5. Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand. Endocrinology. 2011 Oct; 152(10):3893-904.
    View in: PubMed
    Score: 0.031
  6. Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway. . 2005 Jun; 288(6):C1390-401.
    View in: PubMed
    Score: 0.020
  7. Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells. . 2003 Oct; 285(4):C750-62.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.